Tumors of the pancreas: Difference between revisions
From WikiLectures
No edit summary |
(citation edited) |
||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__TOC__ | __TOC__ | ||
* '''benign tumors''' occur very rarely | * '''benign tumors''' occur very rarely | ||
** [[lipoma]], cystadenomas, dermoid cysts, [[teratomas]] , apudomas | ** [[lipoma]], cystadenomas, dermoid cysts, [[teratomas]] , apudomas | ||
Line 53: | Line 52: | ||
*[[oncomarkers]] - CEA, CA 19-9, CA 50 | *[[oncomarkers]] - CEA, CA 19-9, CA 50 | ||
*differential diagnosis(dif.dg) - benign tumors, pancreatic pseudocysts, [[chronic pancreatitis]] | *differential diagnosis(dif.dg) - benign tumors, pancreatic pseudocysts, [[chronic pancreatitis]] | ||
=== | === Therapy === | ||
Therapy is optimally surgical: | |||
* | *Whipple surgery - in case of head injury - cephalic partial duodenopancreatectomy | ||
* | *cauda involvement - left resection of the pancreas | ||
* | *total duodenopancreatectomy, tube connection gastrojejunoanastomosis | ||
* | * palliative: | ||
** | **in bile duct oppression - biliary anastomoses (see above) | ||
** | **at imminent duodenal oppression - gastrojejunoanastomosis | ||
* | *postoperative measures - glycemic control , or iatrogenic DM therapy - '''this diabetes is very difficult to control due to the absence of glucagon! - great tendency to hypoglycemia !!!''' | ||
* | *pancreatic enzyme substitution | ||
* | *adjuvant - percutaneous conventional RT, it is not very sensitive to CHT, it is used only palliatively | ||
=== | |||
* | === Prognosis === | ||
* | * very unfavorable, operational lethality is 5-15% | ||
* in early diagnosable cancer, 5-year survival is still only 3% | |||
<noinclude> | <noinclude> | ||
== | == Links == | ||
=== | === Source === | ||
* {{ | * {{Cite|type = web|surname1 = Beneš|name1 = Jiří|source_name = Studijní materiály|rok = | ||
| | |cited = 6.5.2010 | ||
|url = http://jirben.wz.cz}} | |url = http://jirben.wz.cz}} | ||
</noinclude> | </noinclude> | ||
[[ | [[Category:Surgery]] | ||
[[ | [[Category:Oncology]] |
Latest revision as of 20:44, 5 January 2024
- benign tumors occur very rarely
- malignant tumors – we distinguish ampular tumors and then pancreatic cancer
Regional pancreatic lymph nodes[edit | edit source]
- upper group - overhead and body
- lower group - under the head and body
- anterior group - pancreatoduodenal, pyloric and proximal mesenteric nodes
- posterior group - posterior pancreatoduodenal, pericholedochal, mesenteric
- lienal group - nodules in the hilus of the spleen
Ampullar (periampullar) tumors[edit | edit source]
- most often it is a well-differentiated adenocarcinoma with papillary exophytic manifestations
- used to be a rare rarity, today it is the fifth most common cause of cancer death
- affects people over 50 years of age
- prognostically favorable is that it soon manifests as obstructive jaundice - therefore it is indicated up to 4 times more *often for resection than pancreatic head cancer
- metastases occur later
Carcinoma[edit | edit source]

- according to the location we recognize - carcinoma of the head, body and cauda pancreas
- occurrence
- is increasingly common (currently about 2 times more than in the interwar period)
- make up over 10% of GIT malignancies, over 3% of all malignancies
- causes - a number of predisposing factors are known - obesity , alcohol, smoking , DM , biliopancreatic reflux, chronic pancreatitis
- localization - 65-70% is in the head, 15% in the body, 5% in the cauda area
- histology - 90% are adenocarcinomas of the ductal epithelium, acinar cell carcinoma has a very poor prognosis
stages of the tumor process[edit | edit source]
- stage I - T1 or 2, N0, M0
- stage II - T3 (infiltration into the stomach, blood vessels), N0, M0
- stage III - any T, N1, M0
- stage IV - any T, N, but M1
Clinical picture[edit | edit source]
- initially presents as:
- "discomfort" syndrome - anorexia, fullness, weight loss and indigestion
- these symptoms should lead to the suspicion of pancreatic malignancy
- pain - in the abdomen and banded in the back
- in head tumor - obstructive jaundice - typical painless onset
Diagnosis[edit | edit source]
Imaging methods are crucial in diagnosis:
- contrast X-ray - typical enlargement of the duodenal window "C"
- USG - identifies the tumor mass, enables FNAB
- ERCP - imaging functions and pancreatic juice collection for cytology
- CT
- arteriography - important for determining tumor operability (infiltration of ports or mesenterics - almost this precludes radical performance)
- oncomarkers - CEA, CA 19-9, CA 50
- differential diagnosis(dif.dg) - benign tumors, pancreatic pseudocysts, chronic pancreatitis
Therapy[edit | edit source]
Therapy is optimally surgical:
- Whipple surgery - in case of head injury - cephalic partial duodenopancreatectomy
- cauda involvement - left resection of the pancreas
- total duodenopancreatectomy, tube connection gastrojejunoanastomosis
- palliative:
- in bile duct oppression - biliary anastomoses (see above)
- at imminent duodenal oppression - gastrojejunoanastomosis
- postoperative measures - glycemic control , or iatrogenic DM therapy - this diabetes is very difficult to control due to the absence of glucagon! - great tendency to hypoglycemia !!!
- pancreatic enzyme substitution
- adjuvant - percutaneous conventional RT, it is not very sensitive to CHT, it is used only palliatively
Prognosis[edit | edit source]
- very unfavorable, operational lethality is 5-15%
- in early diagnosable cancer, 5-year survival is still only 3%
Links[edit | edit source]
Source[edit | edit source]
- BENEŠ, Jiří. Studijní materiály [online]. [cit. 6.5.2010]. <http://jirben.wz.cz>.